126 related articles for article (PubMed ID: 3193847)
1. Phase-shifts of the Bulla ocular circadian pacemaker in the presence of calmodulin antagonists.
Khalsa SB; Block GD
Life Sci; 1988; 43(19):1551-6. PubMed ID: 3193847
[TBL] [Abstract][Full Text] [Related]
2. The Bulla ocular circadian pacemaker. I. Pacemaker neuron membrane potential controls phase through a calcium-dependent mechanism.
McMahon DG; Block GD
J Comp Physiol A; 1987 Aug; 161(3):335-46. PubMed ID: 3668876
[TBL] [Abstract][Full Text] [Related]
3. Calcium channels mediate phase shifts of the Bulla circadian pacemaker.
Khalsa SB; Block GD
J Comp Physiol A; 1988 Dec; 164(2):195-206. PubMed ID: 2854162
[TBL] [Abstract][Full Text] [Related]
4. Phase shifting of the circadian conidiation rhythm in Neurospora crassa by calmodulin antagonists.
Nakashima H
J Biol Rhythms; 1986; 1(2):163-9. PubMed ID: 2980964
[TBL] [Abstract][Full Text] [Related]
5. Calmodulin and protein kinase C antagonists also inhibit the Ca2+-dependent protein protease, calpain I.
Brumley LM; Wallace RW
Biochem Biophys Res Commun; 1989 Mar; 159(3):1297-303. PubMed ID: 2539150
[TBL] [Abstract][Full Text] [Related]
6. FMRFamide modulates the action of phase shifting agents on the ocular circadian pacemakers of Aplysia and Bulla.
Colwell CS; Khalsa SB; Block GD
J Comp Physiol A; 1992 Feb; 170(2):211-5. PubMed ID: 1583606
[TBL] [Abstract][Full Text] [Related]
7. Calmodulin antagonists induce changes in lens permeability and transparency.
Sanderson J; Gandolfi SA; Duncan G
Curr Eye Res; 1994 Mar; 13(3):219-24. PubMed ID: 8194370
[TBL] [Abstract][Full Text] [Related]
8. Identification of calmodulin-like activity in term human amnion: effect of calmodulin inhibitors on prostaglandin biosynthesis.
Olson DM; Kramar D; Smieja Z
J Dev Physiol; 1987 Jun; 9(3):271-85. PubMed ID: 3038990
[TBL] [Abstract][Full Text] [Related]
9. Comparative antiarrhythmic and electrophysiological effects of drugs known to inhibit calmodulin (TFP, W7 and bepridil).
Barron E; Marshall RJ; Martorana M; Winslow E
Br J Pharmacol; 1986 Nov; 89(3):603-12. PubMed ID: 3492234
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of protein synthesis by antagonists of calmodulin in Ehrlich ascites tumor cells.
Kumar RV; Panniers R; Wolfman A; Henshaw EC
Eur J Biochem; 1991 Jan; 195(2):313-9. PubMed ID: 1997317
[TBL] [Abstract][Full Text] [Related]
11. On the role of Ca2(+)-calmodulin-dependent and cAMP-dependent protein phosphorylation in the circadian rhythm of Neurospora crassa.
Techel D; Gebauer G; Kohler W; Braumann T; Jastorff B; Rensing L
J Comp Physiol B; 1990; 159(6):695-706. PubMed ID: 2159489
[TBL] [Abstract][Full Text] [Related]
12. Stage-dependent inhibition of Plasmodium falciparum by potent Ca2+ and calmodulin modulators.
Tanabe K; Izumo A; Kato M; Miki A; Doi S
J Protozool; 1989; 36(2):139-43. PubMed ID: 2657032
[TBL] [Abstract][Full Text] [Related]
13. Trifluoperazine and calmidazolium have multiple actions on the release of noradrenaline from sympathetic nerves of mouse atria.
Barrington M; Majewski H
Naunyn Schmiedebergs Arch Pharmacol; 1994 Feb; 349(2):133-9. PubMed ID: 7513380
[TBL] [Abstract][Full Text] [Related]
14. Light-induced phase shifting of the circadian conidiation rhythm is inhibited by calmodulin antagonists in Neurospora crassa.
Sadakane Y; Nakashima H
J Biol Rhythms; 1996 Sep; 11(3):234-40. PubMed ID: 8872595
[TBL] [Abstract][Full Text] [Related]
15. Effects of calmodulin antagonists on calcium transport by chorioallantoic membranes of developing chicken embryos.
Blank JA; Waite LC
Res Commun Chem Pathol Pharmacol; 1992 Feb; 75(2):131-41. PubMed ID: 1570400
[TBL] [Abstract][Full Text] [Related]
16. Effect of calmodulin antagonists on contraction and 45Ca movements in rat aorta.
Wermelskirchen D; Koch P; Wilhelm D; Nebel U; Leidig A; Wilffert B; Peters T
Pharmacology; 1989; 39(5):317-26. PubMed ID: 2616634
[TBL] [Abstract][Full Text] [Related]
17. Calcium transport by sarcoplasmic reticulum of vascular smooth muscle: II. Effects of calmodulin and calmodulin inhibitors.
Stout MA; Silver PJ
J Cell Physiol; 1992 Oct; 153(1):169-75. PubMed ID: 1522130
[TBL] [Abstract][Full Text] [Related]
18. Effect of calmodulin antagonists on phospholipase D activity in SH-SY5Y cells.
del Carmen Boyano-Adánez M; Gustavsson L
Neurochem Int; 2002 Mar; 40(3):261-8. PubMed ID: 11741010
[TBL] [Abstract][Full Text] [Related]
19. Phase-shifting of a neuronal circadian pacemaker in Bulla gouldiana by pentylenetetrazol.
Khalsa SB; Block GD
Comp Biochem Physiol C Comp Pharmacol Toxicol; 1992 Apr; 101(3):557-60. PubMed ID: 1354133
[TBL] [Abstract][Full Text] [Related]
20. Calmodulin antagonists stimulate renin secretion and inhibit renin synthesis in vitro.
Della Bruna R; Pinet F; Corvol P; Kurtz A
Am J Physiol; 1992 Mar; 262(3 Pt 2):F397-402. PubMed ID: 1558157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
